China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Safety and efficacy of remimazolam combined with esketamine and remifentanil in bronchoscopy: A prospective randomized controlled study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133870
Registration Time: 2026/10/08
Type: Interventional study
Primary Sponsor: Medical Ethics Review Committee
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337825
Published by HT Digital Content Services with permission from Health Daily Digest....